Helsinn Group grants exclusive licensing rights to MENARINI for Pracinostat EN

Lugano, Switzerland and Florence, Italy, December 21, 2018: Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MENARINI, an Italian biopharmaceutical Group active in 136 countries worldwide, today announced that BERLIN-CHEMIE AG, a German subsidiary of the MENARINI Group, has been granted exclusive licensing rights to commercialize Pracinostat worldwide (excluding US, Canada, Japan and South America). EN
Read more

Further topics